Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV003482626 | SCV004229483 | uncertain significance | not provided | 2023-07-07 | criteria provided, single submitter | clinical testing | Available data are insufficient to determine the clinical significance of the variant at this time. This variant is expected to severely impact normal RNA splicing, resulting in the loss of a functional protein, however, it is not known if such variants in this gene are associated with disease. Assessment of experimental evidence regarding the effect of this variant on protein function is inconclusive. Results indicate reduced signaling properties in vitro, however, this is not consistent with the disease mechanism for CADASIL (PMID: 31960911). This variant has not been reported in large, multi-ethnic general populations (http://gnomad.broadinstitute.org). |